RXRX Recursion Pharmaceuticals, Inc.

RXRX (Recursion Pharmaceuticals, Inc.) is a US stock trading at $2.95, -2.26% on the day. mdvin's smart-money engine places it in the WATCHING operator phase, with a GRINDER accumulation style. Current conviction is 46/100 and the Buy Score is 21. The active signal is QUIET. It has ignited 5 time(s) in the last 90 sessions, paying off 48% of the time (typical run +6.8%). Reversal/trap risk is graded MEDIUM. It is currently a Coiled Spring (readiness 61/100) — sitting in the quiet state that preceded its own past breakouts. On fundamentals it looks undervalued (quality grade F, analyst upside +147.20%).